A randomised, double-blind, placebo-controlled trial of Lactobacillus reuteri DSM 17938 in patients with severe infantile colic
Latest Information Update: 30 Nov 2015
At a glance
- Drugs Limosilactobacillus reuteri (Primary)
- Indications Colic
- Focus Therapeutic Use
Most Recent Events
- 30 Nov 2015 New trial record